Insiders who reported open-market trades in the last 12 months at the companies Column Group IV GP, LP files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Josh Wolfe - $5.00M in EIKN purchases and sales in the last 12 months
Column Group IV GP, LP is an investment firm, tracked as 10% Owner of Eikon Therapeutics, Inc. (EIKN). InsiderAlpha holds 2 primary Form 4 filings for it, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Column Group IV GP, LP submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Column Group IV GP, LP been buying or selling stock?
Recorded transactions: 4 open-market purchases ($39.15M) and 0 open-market sales across all tracked filings.
Column Group IV GP, LP is 10% Owner of Eikon Therapeutics, Inc. (EIKN). 2 SEC Form 4 filings on record, most recently on 8 September 2026. Most recent open-market trade: bought $1.03M of EIKN on 8 September 2026. Lifetime open-market purchases: $39.15M.
Recent transactions
11
The latest 11 SEC Form 4 transactions reported by Column Group IV GP, LP.
InsiderAlpha's records for Column Group IV GP, LP go back to 2026: 2 primary Form 4 filings, an average of 2.0 per year. The typical open-market purchase is $9.79M (4 buys totaling $39.15M). The largest single buy on record is $25.87M of EIKN in 2026. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
